Miriana Mariussi

Miriana Mariussi

Auto-generated profile, based on publicly available information

Miriana Mariussi

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Ophthalmology
Verified
Journal Article
Closed access
DZDinah Zur
Dinah Zur
MIMatias Iglicki
Matias Iglicki
CBCatharina Busch
Catharina Busch
AIAlessandro Invernizzi
Alessandro Invernizzi
MMMiriana Mariussi
Miriana Mariussi
ASAnna Sala-Puigdollers
Anna Sala-Puigdollers

23 January 2026 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
FMFelipe A. Mourato
Felipe A. Mourato
LSLuiza Giuliani Schmitt
Luiza Giuliani Schmitt
MMMiriana Mariussi
Miriana Mariussi
GTGiovanni Torri
Giovanni Torri
SAStephan Altmayer
Stephan Altmayer
ADAdriano B. Dias
Adriano B. Dias
Purpose of the Report: The PRIMARY score standardizes interpretation of PSMA PET for intraprostatic assessment of clinically significant prostate cancer (csPCa). Although early studies are promising, no meta-analysis has systematically evaluated its accuracy. We aimed to assess the diagnostic performance of PRIMARY and compare it with PI-RADS. Material and Methods: A systematic review and meta-analysis were performed according to PRISMA-DTA guidelines. Studies assessing the PRIMARY score on PSMA PET/CT or PET/MRI for csPCa detection were included. The primary analysis focused on biopsy-naïve patients; secondary analyses incorporated all studies irrespective of prior histology, evaluated thresholds (≥3 vs. ≥4), compared PRIMARY with PI-RADS, and examined combined performance. Pooled sensitivity and specificity were estimated with a bivariate random-effects model. Results: Thirteen studies (n=1974) were included. In biopsy-naïve cohorts (6 studies), PRIMARY ≥3 achieved pooled sensitivity/specificity of 90% (95% CI: 86%–93%) and 63% (95% CI: 57%–69%). In an expanded analysis of 9 studies regardless of prior biopsy, values were 87% (82%–90%) and 56% (46%–65%). Across 5 studies directly comparing thresholds, raising the cutoff from ≥3 to ≥4 reduced sensitivity from 89% to 81% but increased specificity from 53% to 72%. Three head-to-head studies showed comparable accuracy between PRIMARY and PI-RADS. Conclusions: PRIMARY demonstrates high sensitivity and moderate specificity for csPCa, comparable to PI-RADS. In biopsy-naïve men it shows robust performance, and combination with mpMRI further improves sensitivity. Threshold selection should reflect clinical intent, supporting PRIMARY as a tool for pre-biopsy risk stratification and integrated diagnostic workflows.

11 July 2025 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
DTDebora Mayumi Takamune
Debora Mayumi Takamune
JMJoao Miranda
Joao Miranda
MMMiriana Mariussi
Miriana Mariussi
TPThais Reif de Paula
Thais Reif de Paula
YMYousef Mazaheri
Yousef Mazaheri
Natally HorvatNatally Horvat
Natally Horvat

8 April 2026 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
MMMiriana Mariussi
Miriana Mariussi
LLLaura Costa de Oliveira Lima
Laura Costa de Oliveira Lima
MRMariano Gallo Ruelas
Mariano Gallo Ruelas
VOVictor Arthur Ohannesian
Victor Arthur Ohannesian
BMBruno Murad
Bruno Murad
RGRodrigo Gobbo Garcia
Rodrigo Gobbo Garcia
Objective: The aim of this meta-analysis was to determine the efficacy and safety of percutaneous irreversible electroporation combined with immunotherapy compared with irreversible electroporation alone in patients with locally advanced pancreatic cancer. Methods: We systematically searched Embase, Cochrane Central Register of Controlled Trials, and PubMed/Medline for relevant studies. The outcomes of interest were progression-free survival, overall survival, carbohydrate antigen 19-9 (CA 19-9) levels, and adverse events. Progression-free survival and overall survival were assessed using pooled hazard ratios (HR), odds

1 July 2024 in Contemporary Diagnostic Radiology
Verified
Journal Article
Closed access
MMMiriana Mariussi
Miriana Mariussi
SGSofia Gambetta
Sofia Gambetta
The peritoneal cavity is commonly affected by disease processes such as bowel perforation, infections, malignancy, and trauma. Recognizing the anatomy of the peritoneal and retroperitoneal regions is essential for identifying diseases and formulating differential diagnoses during radiological interpretation. Understanding how diseases can spread through the abdomen and pelvis is crucial for an accurate interpretation of radiological findings. Radiologists must be familiar with the peritoneal and retroperitoneal anatomy to avoid potential diagnostic misinterpretations. This article aims to discuss the anatomic principles of peritoneal ligaments and spaces, retroperitoneal spaces and planes, review the basic embryological development of the peritoneum, describe the mechanism by which diseases spread through the abdomen and pelvis, and provide key diagnostic findings.

14 August 2024 in Current Problems in Diagnostic Radiology
Verified
Journal Article
Closed access
MMMiriana Mariussi
Miriana Mariussi
PAPaula Terra Amaral
Paula Terra Amaral
EFEduardo Kaiser Ururahy Nunes Fonseca
Eduardo Kaiser Ururahy Nunes Fonseca
GTGustavo Teles
Gustavo Teles
PFPriscila Mina Falsarella
Priscila Mina Falsarella
RGRodrigo Gobbo Garcia
Rodrigo Gobbo Garcia